Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07153536 · ClinicalTrials.gov registry record · NA

Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis

A NA study of Stroke and Hemiparesis After Stroke, sponsored by Marco Capogrosso.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07153536: Recruiting NA study of Stroke and Hemiparesis After Stroke, sponsored by Marco Capogrosso.

NCT07153536 is a NA study of Stroke and Hemiparesis After Stroke that is actively recruiting participants, run by Marco Capogrosso. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07153536, a NA study of Stroke and Hemiparesis After Stroke, is actively recruiting participants, sponsored by Marco Capogrosso.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study plans to use systems that have been developed by Medtronic to investigate the use of cervical spinal cord stimulation to treat adults with upper limb hemiparesis resulting from a stroke. The spinal cord stimulation (SCS) will be combined with physical training to improve arm and hand motor control. The study is divided into three phases. In the first phase, after baseline assessments, participants will undergo a Physical Training Protocol (PTP) for 6 weeks including 3 sessions of 90 mins/session per week. After receiving the Medtronic implantable system, in Phase 2, they will then repeat the same PTP program in combination with spinal cord stimulation during the entirety of each of the rehabilitation sessions. Finally, in Phase 3, participants will go home, will not be able to use the stimulation at home but will participate in monthly assessments in the laboratory in which the functionality of the Medtronic system and their motor performances will be assessed for up to 6 months.

Primary Outcome

Success Criteria: no serious adverse events related to the stimulation or intolerable. adverse events reported

Interventions

  • OTHER Physical Therapy
  • DEVICE Spinal Cord Stimulator (Medtronic Inceptiv™ System)

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-01-06
Est. Completion 2028-01
Phase NA
Marco Capogrosso

3 total trials

What NCT07153536 shows while recruiting

NCT07153536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Physical Therapy is the first listed.

NCT07153536 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07153536 about?

NCT07153536 is a clinical study titled "Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis". This study plans to use systems that have been developed by Medtronic to investigate the use of cervical spinal cord stimulation to treat adults with upper limb hemiparesis resulting from a stroke. The spinal cord stimulation (SCS) will be combined with physical training to improve arm and hand moto...

What is the current status of trial NCT07153536?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-06. Estimated completion is 2028-01.

What conditions does trial NCT07153536 study?

This clinical trial studies the following conditions: Stroke, Hemiparesis After Stroke, Spinal Cord Injuries and Disorders.

What interventions are being tested in trial NCT07153536?

The interventions under investigation include: Physical Therapy (OTHER), Spinal Cord Stimulator (Medtronic Inceptiv™ System) (DEVICE).

Who is sponsoring clinical trial NCT07153536?

This trial is sponsored by Marco Capogrosso, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07153536 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07153536's enrollment target sits among peer trials

20 361st of 454 higher than 74 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07153536, the US trial registry maintained by the National Library of Medicine. NCT07153536 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.